• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

难治性心源性休克患者严重二尖瓣反流的紧急经导管缘对缘修复术

Urgent Transcatheter Edge-to-Edge Repair for Severe Mitral Regurgitation in Patients with Refractory Cardiogenic Shock.

作者信息

Perel Nimrod, Asher Elad, Taha Luoay, Levy Nir, Steinmetz Yoed, Karameh Hani, Karmi Mohammad, Maller Tomer, Harari Emanuel, Dvir Danny, Glikson Michael, Carasso Shemy, Shuvy Mony

机构信息

Jesselson Integrated Heart Centre, Shaare Zedek Medical Center and Faculty of Medicine, Hebrew University, 12, Shmu'el Bait, P.O. 3235, Jerusalem 9103102, Israel.

The Azrieli Faculty of Medicine, Bar Ilan University, Zefat 1311502, Israel.

出版信息

J Clin Med. 2022 Sep 23;11(19):5617. doi: 10.3390/jcm11195617.

DOI:10.3390/jcm11195617
PMID:36233485
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC9573095/
Abstract

Introduction Patients suffering from cardiogenic shock (CS) and mitral regurgitation (MR) demonstrate worse prognosis, with higher mortality rates. We sought to evaluate the effectiveness of urgent valve intervention of the mitral valve, using transcatheter edge-to-edge repair (TEER) procedures in patients presenting with CS in a tertiary Intensive Coronary Care Unit (ICCU). Methods and Results Patients with unremitting CS and severe MR were selected for urgent TEER. Baseline clinical and echocardiographic characteristics were recorded, as well as procedural success (MR severity and hemodynamics), and 30-days and 6-month mortality. Urgent TEER was done in 13 patients, whose average age was 70 years; 12 (92%) of the patients were male. All 13 patients had suffered previous ischemic heart disease-12 (92%) with either acute severe MR or worsening of previously known MR by an acute ischemic event. Using the SCAI criteria, 8 patients (61%) were classified as 'E' (Extreme) category; 4 (31%) were classified as 'C'. At 30 days, 12 out of the 13 patients survived (corresponding to an 8% mortality rate); all of those 12 patients remained alive at 6 months post-admission/procedure. Conclusions The use of TEER was associated with greater 30-day and 6-month survival rates, compared to the worldwide mortality rates of patients admitted with CS. This finding may change the previous paradigm that CS and MR are associated with the worst outcome, and we might be able to offer these patients a safe and effective therapeutic option.

摘要

引言

患有心源性休克(CS)和二尖瓣反流(MR)的患者预后较差,死亡率较高。我们试图评估在三级重症冠心病监护病房(ICCU)中,对出现CS的患者使用经导管缘对缘修复(TEER)手术进行二尖瓣紧急瓣膜干预的有效性。

方法与结果

选择患有持续性CS和严重MR的患者进行紧急TEER。记录基线临床和超声心动图特征,以及手术成功率(MR严重程度和血流动力学)、30天和6个月死亡率。13例患者接受了紧急TEER,平均年龄70岁;其中12例(92%)为男性。所有13例患者既往均患有缺血性心脏病,其中12例(92%)伴有急性严重MR或因急性缺血事件导致既往已知的MR恶化。根据SCAI标准,8例患者(61%)被归类为“E”(极重度)类别;4例(31%)被归类为“C”类别。30天时,13例患者中有12例存活(死亡率为8%);这12例患者在入院/手术后6个月均存活。

结论

与全球CS患者的死亡率相比,TEER的使用与更高的30天和6个月生存率相关。这一发现可能会改变之前认为CS和MR与最差预后相关的模式,我们或许能够为这些患者提供一种安全有效的治疗选择。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ac26/9573095/002e52289d11/jcm-11-05617-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ac26/9573095/e14c244ca83d/jcm-11-05617-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ac26/9573095/002e52289d11/jcm-11-05617-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ac26/9573095/e14c244ca83d/jcm-11-05617-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ac26/9573095/002e52289d11/jcm-11-05617-g002.jpg

相似文献

1
Urgent Transcatheter Edge-to-Edge Repair for Severe Mitral Regurgitation in Patients with Refractory Cardiogenic Shock.难治性心源性休克患者严重二尖瓣反流的紧急经导管缘对缘修复术
J Clin Med. 2022 Sep 23;11(19):5617. doi: 10.3390/jcm11195617.
2
Use of edge-to-edge percutaneous mitral valve repair for severe mitral regurgitation in cardiogenic shock: A multicenter observational experience (MITRA-SHOCK study).应用缘对缘经皮二尖瓣修复术治疗心原性休克合并重度二尖瓣反流:一项多中心观察性研究(MITRA-SHOCK 研究)。
Catheter Cardiovasc Interv. 2021 Jul 1;98(1):E163-E170. doi: 10.1002/ccd.29683. Epub 2021 Apr 2.
3
Cardiogenic shock and severe secondary mitral regurgitation successfully treated with transcatheter edge-to-edge repair: a case report.经导管缘对缘修复术成功治疗心源性休克和严重继发性二尖瓣反流:一例报告
Eur Heart J Case Rep. 2023 Jun 7;7(6):ytad240. doi: 10.1093/ehjcr/ytad240. eCollection 2023 Jun.
4
Investigation of outcomes following transcatheter edge to edge repair of the mitral valve versus medical management alone in patients with cardiogenic shock and mitral regurgitation.在心源性休克和二尖瓣反流患者中,经导管二尖瓣缘对缘修复与单纯药物治疗后的结局研究。
Am Heart J Plus. 2024 Jul 29;45:100430. doi: 10.1016/j.ahjo.2024.100430. eCollection 2024 Sep.
5
Transcatheter edge-to-edge repair in patients with mitral regurgitation and cardiogenic shock: a new therapeutic target.经导管缘对缘修复术治疗二尖瓣反流合并心原性休克:一个新的治疗靶点。
Curr Opin Crit Care. 2022 Aug 1;28(4):426-433. doi: 10.1097/MCC.0000000000000952.
6
Predictors of optimal procedural result after transcatheter edge-to-edge mitral valve repair in secondary mitral regurgitation.经导管缘对缘二尖瓣修复术治疗继发性二尖瓣反流后达到最佳手术效果的预测因素。
Catheter Cardiovasc Interv. 2022 Apr;99(5):1626-1635. doi: 10.1002/ccd.30062. Epub 2022 Jan 15.
7
Transcatheter Edge-to-Edge Repair for Acute Mitral Regurgitation With Cardiogenic Shock Secondary to Mechanical Complication.经导管缘对缘修复术治疗机械性并发症继发心源性休克的急性二尖瓣反流
Cardiovasc Revasc Med. 2022 Dec;45:44-50. doi: 10.1016/j.carrev.2022.07.003. Epub 2022 Jul 11.
8
Clinical Impact of Tricuspid Regurgitation on Transcatheter Edge-to-Edge Mitral Valve Repair for Mitral Regurgitation.三尖瓣反流对二尖瓣反流经导管缘对缘修复术的临床影响。
Cardiovasc Revasc Med. 2022 Aug;41:1-9. doi: 10.1016/j.carrev.2022.01.027. Epub 2022 Feb 5.
9
Survival Following Edge-to-Edge Transcatheter Mitral Valve Repair in Patients With Cardiogenic Shock: A Nationwide Analysis.心原性休克患者行边缘对边缘经导管二尖瓣修复术后的生存情况:一项全国性分析。
J Am Heart Assoc. 2021 Apr 20;10(8):e019882. doi: 10.1161/JAHA.120.019882. Epub 2021 Apr 6.
10
Outcomes After Transcatheter Edge-to-Edge Mitral Valve Repair According to Mitral Regurgitation Etiology and Cardiac Remodeling.根据二尖瓣反流病因和心脏重构的经导管缘对缘二尖瓣修复术后的结果。
JACC Cardiovasc Interv. 2022 Sep 12;15(17):1711-1722. doi: 10.1016/j.jcin.2022.07.004.

引用本文的文献

1
Clinical outcomes of transcatheter edge-to-edge repair in patients with acute mitral regurgitation complicated by cardiogenic shock: a systematic review and meta-analysis.经导管缘对缘修复术治疗急性二尖瓣反流合并心源性休克患者的临床结局:一项系统评价和荟萃分析
BMC Cardiovasc Disord. 2025 May 19;25(1):380. doi: 10.1186/s12872-025-04844-z.
2
Transcatheter Edge-to-Edge Repair for Severe Mitral Regurgitation in Patients With Cardiogenic Shock: A Systematic Review and Meta-Analysis.心源性休克患者严重二尖瓣反流的经导管缘对缘修复:系统评价和荟萃分析
J Am Heart Assoc. 2025 Mar 18;14(6):e034932. doi: 10.1161/JAHA.124.034932. Epub 2025 Mar 7.
3

本文引用的文献

1
2021 ESC/EACTS Guidelines for the management of valvular heart disease.2021年欧洲心脏病学会/欧洲心胸外科学会瓣膜性心脏病管理指南。
Eur Heart J. 2022 Feb 12;43(7):561-632. doi: 10.1093/eurheartj/ehab395.
2
Fifteen-Year Trends in Incidence of Cardiogenic Shock Hospitalization and In-Hospital Mortality in the United States.美国心源牲休克住院发病率和住院病死率 15 年变化趋势
J Am Heart Assoc. 2021 Aug 3;10(15):e021061. doi: 10.1161/JAHA.121.021061. Epub 2021 Jul 28.
3
Recommended Standards for the Performance of Transesophageal Echocardiographic Screening for Structural Heart Intervention: From the American Society of Echocardiography.
The Results of Urgent and Emergent Transcatheter Mitral Valve Repair (MitraClip): A Comparison with Standard Elective Repair.
急诊和紧急经导管二尖瓣修复术(MitraClip)的结果:与标准择期修复术的比较
Heart Views. 2024 Jan-Mar;25(1):13-20. doi: 10.4103/heartviews.heartviews_88_23. Epub 2024 Apr 12.
4
Urgent transcatheter edge-to-edge repair for severe mitral regurgitation with flail leaflet in critically Ill patients.危重症患者重度二尖瓣反流伴连枷样瓣叶的紧急经导管缘对缘修复术。
Front Cardiovasc Med. 2023 Jun 16;10:1197345. doi: 10.3389/fcvm.2023.1197345. eCollection 2023.
5
The Battle against Cardiogenic Shock.对抗心源性休克之战
J Clin Med. 2022 Nov 25;11(23):6958. doi: 10.3390/jcm11236958.
经食管超声心动图在结构性心脏介入治疗中筛查的推荐执行标准:来自美国超声心动图学会。
J Am Soc Echocardiogr. 2022 Jan;35(1):1-76. doi: 10.1016/j.echo.2021.07.006. Epub 2021 Jul 17.
4
2020 ESC Guidelines for the management of acute coronary syndromes in patients presenting without persistent ST-segment elevation.2020年欧洲心脏病学会非持续性ST段抬高型急性冠状动脉综合征患者管理指南
Rev Esp Cardiol (Engl Ed). 2021 Jun;74(6):544. doi: 10.1016/j.rec.2021.05.002.
5
Survival Following Edge-to-Edge Transcatheter Mitral Valve Repair in Patients With Cardiogenic Shock: A Nationwide Analysis.心原性休克患者行边缘对边缘经导管二尖瓣修复术后的生存情况:一项全国性分析。
J Am Heart Assoc. 2021 Apr 20;10(8):e019882. doi: 10.1161/JAHA.120.019882. Epub 2021 Apr 6.
6
Use of edge-to-edge percutaneous mitral valve repair for severe mitral regurgitation in cardiogenic shock: A multicenter observational experience (MITRA-SHOCK study).应用缘对缘经皮二尖瓣修复术治疗心原性休克合并重度二尖瓣反流:一项多中心观察性研究(MITRA-SHOCK 研究)。
Catheter Cardiovasc Interv. 2021 Jul 1;98(1):E163-E170. doi: 10.1002/ccd.29683. Epub 2021 Apr 2.
7
The management of secondary mitral regurgitation in patients with heart failure: a joint position statement from the Heart Failure Association (HFA), European Association of Cardiovascular Imaging (EACVI), European Heart Rhythm Association (EHRA), and European Association of Percutaneous Cardiovascular Interventions (EAPCI) of the ESC.心力衰竭患者继发性二尖瓣反流的管理:欧洲心脏病学会心力衰竭协会(HFA)、欧洲心血管影像协会(EACVI)、欧洲心脏节律协会(EHRA)和欧洲经皮心血管介入协会(EAPCI)的联合立场声明
Eur Heart J. 2021 Mar 31;42(13):1254-1269. doi: 10.1093/eurheartj/ehab086.
8
Invasive Management of Acute Myocardial Infarction Complicated by Cardiogenic Shock: A Scientific Statement From the American Heart Association.急性心肌梗死并发心源性休克的有创治疗:美国心脏协会的科学声明。
Circulation. 2021 Apr 13;143(15):e815-e829. doi: 10.1161/CIR.0000000000000959. Epub 2021 Mar 4.
9
Transcatheter Mitral Valve Repair in Cardiogenic Shock and Mitral Regurgitation: A Patient-Level, Multicenter Analysis.心源性休克合并二尖瓣反流的经导管二尖瓣修复术:一项患者水平的多中心分析
JACC Cardiovasc Interv. 2021 Jan 11;14(1):1-11. doi: 10.1016/j.jcin.2020.08.037. Epub 2020 Oct 14.
10
SCAI clinical expert consensus statement on the classification of cardiogenic shock: This document was endorsed by the American College of Cardiology (ACC), the American Heart Association (AHA), the Society of Critical Care Medicine (SCCM), and the Society of Thoracic Surgeons (STS) in April 2019.美国心脏病学会(ACC)、美国心脏协会(AHA)、重症医学会(SCCM)和胸外科医师学会(STS)于 2019 年 4 月共同发布了心血管造影协会(SCAI)关于心源性休克分类的临床专家共识声明。
Catheter Cardiovasc Interv. 2019 Jul 1;94(1):29-37. doi: 10.1002/ccd.28329. Epub 2019 May 19.